Logo image of FOSL

FOSSIL GROUP INC (FOSL) Stock Fundamental Analysis

NASDAQ:FOSL - US34988V1061 - Common Stock

2.995 USD
-0.06 (-2.12%)
Last: 8/28/2025, 11:23:00 AM
Fundamental Rating

1

FOSL gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 50 industry peers in the Textiles, Apparel & Luxury Goods industry. Both the profitability and financial health of FOSL have multiple concerns. FOSL has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

FOSL had negative earnings in the past year.
FOSL had a negative operating cash flow in the past year.
In the past 5 years FOSL reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: FOSL reported negative operating cash flow in multiple years.
FOSL Yearly Net Income VS EBIT VS OCF VS FCFFOSL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

Looking at the Return On Assets, with a value of -8.44%, FOSL is doing worse than 70.00% of the companies in the same industry.
FOSL's Return On Equity of -39.57% is on the low side compared to the rest of the industry. FOSL is outperformed by 78.00% of its industry peers.
With a Return On Invested Capital value of 4.80%, FOSL is not doing good in the industry: 62.00% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -8.44%
ROE -39.57%
ROIC 4.8%
ROA(3y)-11.03%
ROA(5y)-7.54%
ROE(3y)-47.24%
ROE(5y)-31.62%
ROIC(3y)N/A
ROIC(5y)N/A
FOSL Yearly ROA, ROE, ROICFOSL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

1.3 Margins

With a Operating Margin value of 2.44%, FOSL is not doing good in the industry: 68.00% of the companies in the same industry are doing better.
FOSL has a Gross Margin of 55.74%. This is in the better half of the industry: FOSL outperforms 66.00% of its industry peers.
FOSL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.44%
PM (TTM) N/A
GM 55.74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.71%
GM growth 5Y1.27%
FOSL Yearly Profit, Operating, Gross MarginsFOSL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

2

2. Health

2.1 Basic Checks

FOSL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for FOSL has been increased compared to 1 year ago.
The number of shares outstanding for FOSL has been increased compared to 5 years ago.
Compared to 1 year ago, FOSL has a worse debt to assets ratio.
FOSL Yearly Shares OutstandingFOSL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
FOSL Yearly Total Debt VS Total AssetsFOSL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

FOSL has an Altman-Z score of 2.01. This is not the best score and indicates that FOSL is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.01, FOSL is not doing good in the industry: 74.00% of the companies in the same industry are doing better.
FOSL has a Debt/Equity ratio of 1.10. This is a high value indicating a heavy dependency on external financing.
FOSL has a Debt to Equity ratio of 1.10. This is in the lower half of the industry: FOSL underperforms 70.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF N/A
Altman-Z 2.01
ROIC/WACC0.4
WACC11.9%
FOSL Yearly LT Debt VS Equity VS FCFFOSL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

FOSL has a Current Ratio of 1.83. This is a normal value and indicates that FOSL is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of FOSL (1.83) is comparable to the rest of the industry.
FOSL has a Quick Ratio of 1.17. This is a normal value and indicates that FOSL is financially healthy and should not expect problems in meeting its short term obligations.
FOSL has a Quick ratio of 1.17. This is comparable to the rest of the industry: FOSL outperforms 52.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.83
Quick Ratio 1.17
FOSL Yearly Current Assets VS Current LiabilitesFOSL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2

3. Growth

3.1 Past

FOSL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 61.39%, which is quite impressive.
Looking at the last year, FOSL shows a very negative growth in Revenue. The Revenue has decreased by -15.34% in the last year.
The Revenue for FOSL have been decreasing by -12.38% on average. This is quite bad
EPS 1Y (TTM)61.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.72%
Revenue 1Y (TTM)-15.34%
Revenue growth 3Y-15.08%
Revenue growth 5Y-12.38%
Sales Q2Q%-15.23%

3.2 Future

FOSL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.64% yearly.
The Revenue is expected to decrease by -10.68% on average over the next years. This is quite bad
EPS Next Y-101.51%
EPS Next 2Y37.65%
EPS Next 3Y29.64%
EPS Next 5YN/A
Revenue Next Year-13.86%
Revenue Next 2Y-16.12%
Revenue Next 3Y-10.68%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
FOSL Yearly Revenue VS EstimatesFOSL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
FOSL Yearly EPS VS EstimatesFOSL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2023 2025 2026 2027 0 2 -2 4 6

1

4. Valuation

4.1 Price/Earnings Ratio

FOSL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for FOSL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FOSL Price Earnings VS Forward Price EarningsFOSL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

88.00% of the companies in the same industry are more expensive than FOSL, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.79
FOSL Per share dataFOSL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

A more expensive valuation may be justified as FOSL's earnings are expected to grow with 29.64% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.65%
EPS Next 3Y29.64%

0

5. Dividend

5.1 Amount

No dividends for FOSL!.
Industry RankSector Rank
Dividend Yield N/A

FOSSIL GROUP INC

NASDAQ:FOSL (8/28/2025, 11:23:00 AM)

2.995

-0.06 (-2.12%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)08-13 2025-08-13/amc
Earnings (Next)11-05 2025-11-05
Inst Owners48.18%
Inst Owner Change1.99%
Ins Owners2.06%
Ins Owner Change3.06%
Market Cap161.10M
Analysts82.86
Price Target5.1 (70.28%)
Short Float %4.15%
Short Ratio4.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)2.91%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.15
P/FCF N/A
P/OCF N/A
P/B 1.07
P/tB 1.08
EV/EBITDA 5.79
EPS(TTM)-1.12
EYN/A
EPS(NY)-0.2
Fwd EYN/A
FCF(TTM)-0.89
FCFYN/A
OCF(TTM)-0.8
OCFYN/A
SpS20.15
BVpS2.79
TBVpS2.78
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.44%
ROE -39.57%
ROCE 6.07%
ROIC 4.8%
ROICexc 6.42%
ROICexgc 6.44%
OM 2.44%
PM (TTM) N/A
GM 55.74%
FCFM N/A
ROA(3y)-11.03%
ROA(5y)-7.54%
ROE(3y)-47.24%
ROE(5y)-31.62%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.71%
GM growth 5Y1.27%
F-Score3
Asset Turnover1.54
Health
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF N/A
Debt/EBITDA 4.1
Cap/Depr 31.55%
Cap/Sales 0.41%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.83
Quick Ratio 1.17
Altman-Z 2.01
F-Score3
WACC11.9%
ROIC/WACC0.4
Cap/Depr(3y)47.98%
Cap/Depr(5y)39.78%
Cap/Sales(3y)0.66%
Cap/Sales(5y)0.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)61.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.72%
EPS Next Y-101.51%
EPS Next 2Y37.65%
EPS Next 3Y29.64%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.34%
Revenue growth 3Y-15.08%
Revenue growth 5Y-12.38%
Sales Q2Q%-15.23%
Revenue Next Year-13.86%
Revenue Next 2Y-16.12%
Revenue Next 3Y-10.68%
Revenue Next 5YN/A
EBIT growth 1Y135.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year29.91%
EBIT Next 3Y52.14%
EBIT Next 5YN/A
FCF growth 1Y-14.84%
FCF growth 3Y0.19%
FCF growth 5YN/A
OCF growth 1Y-53.88%
OCF growth 3Y-2.26%
OCF growth 5YN/A